Review



pcdna flag yap1  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    Addgene inc pcdna flag yap1
    A. Relative activity of TEAD-Gal4-UAS-Luc, a YAP reporter consisting of TEAD1 fused to the GAL4 DNA-binding domain and a UAS-driven firefly luciferase, in NVCMs transfected with empty vector or <t>YAP1</t> expression plasmid and either control or FZD2 siRNA. B. Relative activity of the 8x-TEAD-Luc reporter, which uses 8 copies of the TEAD consensus binding site to express firefly luciferase, in NVCMs transfected with empty vector or YAP1-expression plasmid and control or FZD2 siRNA. C. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector or YAP expression plasmid with or without FZD2 expression vector. D. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector, YAP-expression vector, or expression plasmid for a YAP mutant with serine 127 mutated to alanine (YAP S127A) either alone or in combination with FZD2 expression vector. E. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector, YAP expression plasmid, or YAP S127A expression vector and either control or FZD2 siRNA. F. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector or YAP1 expression plasmid and FZD2 or β-catenin siRNA. G. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector, YAP1 expression vector, FZD2 expression vector, or both FZD2 and YAP1 vectors as well as control or β-catenin siRNA. Graphs represent the mean ± S.D, asterisks indicate p ≤ 0.05 by two-way ANOVA with Tukey’s multiple comparisons test.
    Pcdna Flag Yap1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pcdna flag yap1/product/Addgene inc
    Average 92 stars, based on 6 article reviews
    pcdna flag yap1 - by Bioz Stars, 2026-03
    92/100 stars

    Images

    1) Product Images from "FZD2 inhibits YAP and prevents cell cycle reentry in adult murine cardiomyocytes"

    Article Title: FZD2 inhibits YAP and prevents cell cycle reentry in adult murine cardiomyocytes

    Journal: bioRxiv

    doi: 10.1101/2024.07.26.605158

    A. Relative activity of TEAD-Gal4-UAS-Luc, a YAP reporter consisting of TEAD1 fused to the GAL4 DNA-binding domain and a UAS-driven firefly luciferase, in NVCMs transfected with empty vector or YAP1 expression plasmid and either control or FZD2 siRNA. B. Relative activity of the 8x-TEAD-Luc reporter, which uses 8 copies of the TEAD consensus binding site to express firefly luciferase, in NVCMs transfected with empty vector or YAP1-expression plasmid and control or FZD2 siRNA. C. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector or YAP expression plasmid with or without FZD2 expression vector. D. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector, YAP-expression vector, or expression plasmid for a YAP mutant with serine 127 mutated to alanine (YAP S127A) either alone or in combination with FZD2 expression vector. E. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector, YAP expression plasmid, or YAP S127A expression vector and either control or FZD2 siRNA. F. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector or YAP1 expression plasmid and FZD2 or β-catenin siRNA. G. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector, YAP1 expression vector, FZD2 expression vector, or both FZD2 and YAP1 vectors as well as control or β-catenin siRNA. Graphs represent the mean ± S.D, asterisks indicate p ≤ 0.05 by two-way ANOVA with Tukey’s multiple comparisons test.
    Figure Legend Snippet: A. Relative activity of TEAD-Gal4-UAS-Luc, a YAP reporter consisting of TEAD1 fused to the GAL4 DNA-binding domain and a UAS-driven firefly luciferase, in NVCMs transfected with empty vector or YAP1 expression plasmid and either control or FZD2 siRNA. B. Relative activity of the 8x-TEAD-Luc reporter, which uses 8 copies of the TEAD consensus binding site to express firefly luciferase, in NVCMs transfected with empty vector or YAP1-expression plasmid and control or FZD2 siRNA. C. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector or YAP expression plasmid with or without FZD2 expression vector. D. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector, YAP-expression vector, or expression plasmid for a YAP mutant with serine 127 mutated to alanine (YAP S127A) either alone or in combination with FZD2 expression vector. E. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector, YAP expression plasmid, or YAP S127A expression vector and either control or FZD2 siRNA. F. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector or YAP1 expression plasmid and FZD2 or β-catenin siRNA. G. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector, YAP1 expression vector, FZD2 expression vector, or both FZD2 and YAP1 vectors as well as control or β-catenin siRNA. Graphs represent the mean ± S.D, asterisks indicate p ≤ 0.05 by two-way ANOVA with Tukey’s multiple comparisons test.

    Techniques Used: Activity Assay, Binding Assay, Luciferase, Transfection, Plasmid Preparation, Expressing, Control, Mutagenesis



    Similar Products

    92
    Addgene inc pcdna flag yap1
    A. Relative activity of TEAD-Gal4-UAS-Luc, a YAP reporter consisting of TEAD1 fused to the GAL4 DNA-binding domain and a UAS-driven firefly luciferase, in NVCMs transfected with empty vector or <t>YAP1</t> expression plasmid and either control or FZD2 siRNA. B. Relative activity of the 8x-TEAD-Luc reporter, which uses 8 copies of the TEAD consensus binding site to express firefly luciferase, in NVCMs transfected with empty vector or YAP1-expression plasmid and control or FZD2 siRNA. C. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector or YAP expression plasmid with or without FZD2 expression vector. D. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector, YAP-expression vector, or expression plasmid for a YAP mutant with serine 127 mutated to alanine (YAP S127A) either alone or in combination with FZD2 expression vector. E. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector, YAP expression plasmid, or YAP S127A expression vector and either control or FZD2 siRNA. F. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector or YAP1 expression plasmid and FZD2 or β-catenin siRNA. G. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector, YAP1 expression vector, FZD2 expression vector, or both FZD2 and YAP1 vectors as well as control or β-catenin siRNA. Graphs represent the mean ± S.D, asterisks indicate p ≤ 0.05 by two-way ANOVA with Tukey’s multiple comparisons test.
    Pcdna Flag Yap1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pcdna flag yap1/product/Addgene inc
    Average 92 stars, based on 1 article reviews
    pcdna flag yap1 - by Bioz Stars, 2026-03
    92/100 stars
      Buy from Supplier

    92
    Addgene inc yap 3yf
    A. Relative activity of TEAD-Gal4-UAS-Luc, a YAP reporter consisting of TEAD1 fused to the GAL4 DNA-binding domain and a UAS-driven firefly luciferase, in NVCMs transfected with empty vector or <t>YAP1</t> expression plasmid and either control or FZD2 siRNA. B. Relative activity of the 8x-TEAD-Luc reporter, which uses 8 copies of the TEAD consensus binding site to express firefly luciferase, in NVCMs transfected with empty vector or YAP1-expression plasmid and control or FZD2 siRNA. C. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector or YAP expression plasmid with or without FZD2 expression vector. D. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector, YAP-expression vector, or expression plasmid for a YAP mutant with serine 127 mutated to alanine (YAP S127A) either alone or in combination with FZD2 expression vector. E. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector, YAP expression plasmid, or YAP S127A expression vector and either control or FZD2 siRNA. F. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector or YAP1 expression plasmid and FZD2 or β-catenin siRNA. G. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector, YAP1 expression vector, FZD2 expression vector, or both FZD2 and YAP1 vectors as well as control or β-catenin siRNA. Graphs represent the mean ± S.D, asterisks indicate p ≤ 0.05 by two-way ANOVA with Tukey’s multiple comparisons test.
    Yap 3yf, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/yap 3yf/product/Addgene inc
    Average 92 stars, based on 1 article reviews
    yap 3yf - by Bioz Stars, 2026-03
    92/100 stars
      Buy from Supplier

    92
    Addgene inc pcdna flag yap1 y357f
    (A) Cre-mediated depletion of Csk in MEF cells led to the loss of pSrc Y527 inhibitory phosphorylation and a concomitant increase in pSrc Y416 activating phosphorylation without perturbing ERK phosphorylation. (B) CRISPR-Cas9 genome editing was used to mutate two tyrosine phosphorylation sites ( Yap <t>Y341F/Y357F</t> or Yap Y2F ). (C) Luminal dilation and Mist1 expression defect were not rescued in Csk CKO ; Yap Y2F mutants. (D) Yap tyrosine phosphorylation was reduced but not lost in Yap Y2F homozygous MEF cells. (E) Mutating all three tyrosine residues in a Flag-tagged Yap (Yap Y3F ) led to a complete loss of tyrosine phosphorylation as revealed by Flag or phospho-tyrosine (pY) immunoprecipitation. (F) Schematic diagram of CRISPR-Cas9 genome editing to generate Yap Y341F/Y357F/Y394F ( Yap Y3F ) and Taz Y321F ( Taz YF ) mutant mice. (G) Yap protein remained nuclear in Csk CKO ; Yap Y3F ; Taz YF mutants, resulting in luminal dilation and loss of Mist1 expression. (H) The lumen size was quantified as the ratio of the lumen area versus the overall epithelial area. One-way ANOVA, n=5, *P<0.01. (I) Quantification of Mist1+ cells. One-way ANOVA, n=5, *P<0.0001. Scale bars: 100 µm.
    Pcdna Flag Yap1 Y357f, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pcdna flag yap1 y357f/product/Addgene inc
    Average 92 stars, based on 1 article reviews
    pcdna flag yap1 y357f - by Bioz Stars, 2026-03
    92/100 stars
      Buy from Supplier

    94
    Addgene inc yap1 coding sequence
    (A) Cre-mediated depletion of Csk in MEF cells led to the loss of pSrc Y527 inhibitory phosphorylation and a concomitant increase in pSrc Y416 activating phosphorylation without perturbing ERK phosphorylation. (B) CRISPR-Cas9 genome editing was used to mutate two tyrosine phosphorylation sites ( Yap <t>Y341F/Y357F</t> or Yap Y2F ). (C) Luminal dilation and Mist1 expression defect were not rescued in Csk CKO ; Yap Y2F mutants. (D) Yap tyrosine phosphorylation was reduced but not lost in Yap Y2F homozygous MEF cells. (E) Mutating all three tyrosine residues in a Flag-tagged Yap (Yap Y3F ) led to a complete loss of tyrosine phosphorylation as revealed by Flag or phospho-tyrosine (pY) immunoprecipitation. (F) Schematic diagram of CRISPR-Cas9 genome editing to generate Yap Y341F/Y357F/Y394F ( Yap Y3F ) and Taz Y321F ( Taz YF ) mutant mice. (G) Yap protein remained nuclear in Csk CKO ; Yap Y3F ; Taz YF mutants, resulting in luminal dilation and loss of Mist1 expression. (H) The lumen size was quantified as the ratio of the lumen area versus the overall epithelial area. One-way ANOVA, n=5, *P<0.01. (I) Quantification of Mist1+ cells. One-way ANOVA, n=5, *P<0.0001. Scale bars: 100 µm.
    Yap1 Coding Sequence, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/yap1 coding sequence/product/Addgene inc
    Average 94 stars, based on 1 article reviews
    yap1 coding sequence - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    94
    Addgene inc nucleofection pcdna flag yap1
    (A) Cre-mediated depletion of Csk in MEF cells led to the loss of pSrc Y527 inhibitory phosphorylation and a concomitant increase in pSrc Y416 activating phosphorylation without perturbing ERK phosphorylation. (B) CRISPR-Cas9 genome editing was used to mutate two tyrosine phosphorylation sites ( Yap <t>Y341F/Y357F</t> or Yap Y2F ). (C) Luminal dilation and Mist1 expression defect were not rescued in Csk CKO ; Yap Y2F mutants. (D) Yap tyrosine phosphorylation was reduced but not lost in Yap Y2F homozygous MEF cells. (E) Mutating all three tyrosine residues in a Flag-tagged Yap (Yap Y3F ) led to a complete loss of tyrosine phosphorylation as revealed by Flag or phospho-tyrosine (pY) immunoprecipitation. (F) Schematic diagram of CRISPR-Cas9 genome editing to generate Yap Y341F/Y357F/Y394F ( Yap Y3F ) and Taz Y321F ( Taz YF ) mutant mice. (G) Yap protein remained nuclear in Csk CKO ; Yap Y3F ; Taz YF mutants, resulting in luminal dilation and loss of Mist1 expression. (H) The lumen size was quantified as the ratio of the lumen area versus the overall epithelial area. One-way ANOVA, n=5, *P<0.01. (I) Quantification of Mist1+ cells. One-way ANOVA, n=5, *P<0.0001. Scale bars: 100 µm.
    Nucleofection Pcdna Flag Yap1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nucleofection pcdna flag yap1/product/Addgene inc
    Average 94 stars, based on 1 article reviews
    nucleofection pcdna flag yap1 - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    94
    Addgene inc pcdna flag yap
    (A) Cre-mediated depletion of Csk in MEF cells led to the loss of pSrc Y527 inhibitory phosphorylation and a concomitant increase in pSrc Y416 activating phosphorylation without perturbing ERK phosphorylation. (B) CRISPR-Cas9 genome editing was used to mutate two tyrosine phosphorylation sites ( Yap <t>Y341F/Y357F</t> or Yap Y2F ). (C) Luminal dilation and Mist1 expression defect were not rescued in Csk CKO ; Yap Y2F mutants. (D) Yap tyrosine phosphorylation was reduced but not lost in Yap Y2F homozygous MEF cells. (E) Mutating all three tyrosine residues in a Flag-tagged Yap (Yap Y3F ) led to a complete loss of tyrosine phosphorylation as revealed by Flag or phospho-tyrosine (pY) immunoprecipitation. (F) Schematic diagram of CRISPR-Cas9 genome editing to generate Yap Y341F/Y357F/Y394F ( Yap Y3F ) and Taz Y321F ( Taz YF ) mutant mice. (G) Yap protein remained nuclear in Csk CKO ; Yap Y3F ; Taz YF mutants, resulting in luminal dilation and loss of Mist1 expression. (H) The lumen size was quantified as the ratio of the lumen area versus the overall epithelial area. One-way ANOVA, n=5, *P<0.01. (I) Quantification of Mist1+ cells. One-way ANOVA, n=5, *P<0.0001. Scale bars: 100 µm.
    Pcdna Flag Yap, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pcdna flag yap/product/Addgene inc
    Average 94 stars, based on 1 article reviews
    pcdna flag yap - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    94
    Addgene inc plasmid dna
    (A) Cre-mediated depletion of Csk in MEF cells led to the loss of pSrc Y527 inhibitory phosphorylation and a concomitant increase in pSrc Y416 activating phosphorylation without perturbing ERK phosphorylation. (B) CRISPR-Cas9 genome editing was used to mutate two tyrosine phosphorylation sites ( Yap <t>Y341F/Y357F</t> or Yap Y2F ). (C) Luminal dilation and Mist1 expression defect were not rescued in Csk CKO ; Yap Y2F mutants. (D) Yap tyrosine phosphorylation was reduced but not lost in Yap Y2F homozygous MEF cells. (E) Mutating all three tyrosine residues in a Flag-tagged Yap (Yap Y3F ) led to a complete loss of tyrosine phosphorylation as revealed by Flag or phospho-tyrosine (pY) immunoprecipitation. (F) Schematic diagram of CRISPR-Cas9 genome editing to generate Yap Y341F/Y357F/Y394F ( Yap Y3F ) and Taz Y321F ( Taz YF ) mutant mice. (G) Yap protein remained nuclear in Csk CKO ; Yap Y3F ; Taz YF mutants, resulting in luminal dilation and loss of Mist1 expression. (H) The lumen size was quantified as the ratio of the lumen area versus the overall epithelial area. One-way ANOVA, n=5, *P<0.01. (I) Quantification of Mist1+ cells. One-way ANOVA, n=5, *P<0.0001. Scale bars: 100 µm.
    Plasmid Dna, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/plasmid dna/product/Addgene inc
    Average 94 stars, based on 1 article reviews
    plasmid dna - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    Image Search Results


    A. Relative activity of TEAD-Gal4-UAS-Luc, a YAP reporter consisting of TEAD1 fused to the GAL4 DNA-binding domain and a UAS-driven firefly luciferase, in NVCMs transfected with empty vector or YAP1 expression plasmid and either control or FZD2 siRNA. B. Relative activity of the 8x-TEAD-Luc reporter, which uses 8 copies of the TEAD consensus binding site to express firefly luciferase, in NVCMs transfected with empty vector or YAP1-expression plasmid and control or FZD2 siRNA. C. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector or YAP expression plasmid with or without FZD2 expression vector. D. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector, YAP-expression vector, or expression plasmid for a YAP mutant with serine 127 mutated to alanine (YAP S127A) either alone or in combination with FZD2 expression vector. E. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector, YAP expression plasmid, or YAP S127A expression vector and either control or FZD2 siRNA. F. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector or YAP1 expression plasmid and FZD2 or β-catenin siRNA. G. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector, YAP1 expression vector, FZD2 expression vector, or both FZD2 and YAP1 vectors as well as control or β-catenin siRNA. Graphs represent the mean ± S.D, asterisks indicate p ≤ 0.05 by two-way ANOVA with Tukey’s multiple comparisons test.

    Journal: bioRxiv

    Article Title: FZD2 inhibits YAP and prevents cell cycle reentry in adult murine cardiomyocytes

    doi: 10.1101/2024.07.26.605158

    Figure Lengend Snippet: A. Relative activity of TEAD-Gal4-UAS-Luc, a YAP reporter consisting of TEAD1 fused to the GAL4 DNA-binding domain and a UAS-driven firefly luciferase, in NVCMs transfected with empty vector or YAP1 expression plasmid and either control or FZD2 siRNA. B. Relative activity of the 8x-TEAD-Luc reporter, which uses 8 copies of the TEAD consensus binding site to express firefly luciferase, in NVCMs transfected with empty vector or YAP1-expression plasmid and control or FZD2 siRNA. C. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector or YAP expression plasmid with or without FZD2 expression vector. D. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector, YAP-expression vector, or expression plasmid for a YAP mutant with serine 127 mutated to alanine (YAP S127A) either alone or in combination with FZD2 expression vector. E. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector, YAP expression plasmid, or YAP S127A expression vector and either control or FZD2 siRNA. F. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector or YAP1 expression plasmid and FZD2 or β-catenin siRNA. G. TEAD-Gal4-UAS-Luc activity in NVCMs transfected with empty vector, YAP1 expression vector, FZD2 expression vector, or both FZD2 and YAP1 vectors as well as control or β-catenin siRNA. Graphs represent the mean ± S.D, asterisks indicate p ≤ 0.05 by two-way ANOVA with Tukey’s multiple comparisons test.

    Article Snippet: NVCMs were also transfected with pRK5- mFzd2 and pcDNA-Flag- Yap1 (AddGene, 42254 and 18881, respectively) and pCMV-Tag2 (Agilent Technologies, 211172) for empty vector controls.

    Techniques: Activity Assay, Binding Assay, Luciferase, Transfection, Plasmid Preparation, Expressing, Control, Mutagenesis

    (A) Cre-mediated depletion of Csk in MEF cells led to the loss of pSrc Y527 inhibitory phosphorylation and a concomitant increase in pSrc Y416 activating phosphorylation without perturbing ERK phosphorylation. (B) CRISPR-Cas9 genome editing was used to mutate two tyrosine phosphorylation sites ( Yap Y341F/Y357F or Yap Y2F ). (C) Luminal dilation and Mist1 expression defect were not rescued in Csk CKO ; Yap Y2F mutants. (D) Yap tyrosine phosphorylation was reduced but not lost in Yap Y2F homozygous MEF cells. (E) Mutating all three tyrosine residues in a Flag-tagged Yap (Yap Y3F ) led to a complete loss of tyrosine phosphorylation as revealed by Flag or phospho-tyrosine (pY) immunoprecipitation. (F) Schematic diagram of CRISPR-Cas9 genome editing to generate Yap Y341F/Y357F/Y394F ( Yap Y3F ) and Taz Y321F ( Taz YF ) mutant mice. (G) Yap protein remained nuclear in Csk CKO ; Yap Y3F ; Taz YF mutants, resulting in luminal dilation and loss of Mist1 expression. (H) The lumen size was quantified as the ratio of the lumen area versus the overall epithelial area. One-way ANOVA, n=5, *P<0.01. (I) Quantification of Mist1+ cells. One-way ANOVA, n=5, *P<0.0001. Scale bars: 100 µm.

    Journal: bioRxiv

    Article Title: Crk mediates Csk-Hippo signaling independently of Yap tyrosine phosphorylation to induce cell extrusion

    doi: 10.1101/2024.06.27.601065

    Figure Lengend Snippet: (A) Cre-mediated depletion of Csk in MEF cells led to the loss of pSrc Y527 inhibitory phosphorylation and a concomitant increase in pSrc Y416 activating phosphorylation without perturbing ERK phosphorylation. (B) CRISPR-Cas9 genome editing was used to mutate two tyrosine phosphorylation sites ( Yap Y341F/Y357F or Yap Y2F ). (C) Luminal dilation and Mist1 expression defect were not rescued in Csk CKO ; Yap Y2F mutants. (D) Yap tyrosine phosphorylation was reduced but not lost in Yap Y2F homozygous MEF cells. (E) Mutating all three tyrosine residues in a Flag-tagged Yap (Yap Y3F ) led to a complete loss of tyrosine phosphorylation as revealed by Flag or phospho-tyrosine (pY) immunoprecipitation. (F) Schematic diagram of CRISPR-Cas9 genome editing to generate Yap Y341F/Y357F/Y394F ( Yap Y3F ) and Taz Y321F ( Taz YF ) mutant mice. (G) Yap protein remained nuclear in Csk CKO ; Yap Y3F ; Taz YF mutants, resulting in luminal dilation and loss of Mist1 expression. (H) The lumen size was quantified as the ratio of the lumen area versus the overall epithelial area. One-way ANOVA, n=5, *P<0.01. (I) Quantification of Mist1+ cells. One-way ANOVA, n=5, *P<0.0001. Scale bars: 100 µm.

    Article Snippet: Plasmids encoding Yap 2YF and Yap 3YF were constructed from pcDNA Flag-Yap1 Y357F (Addgene #18882) through site-directed mutagenesis using Neb Q5 high-fidelity polymerase (New England Biolab #M0491).

    Techniques: Phospho-proteomics, CRISPR, Expressing, Immunoprecipitation, Mutagenesis